OLMA Olema Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 10, 2026
$8.23
· of 52w range
· above low
· to high
$6.6552w low
$36.2652w high
Market Cap (MRQ)
$719M
P/E
-4.4
EPS
$-1.87
your badges
52W Range
$7–$36
Analyst Rating
BUY
Price Target
$36
P/E
-4.4
ROE
-39.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
OLMA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.22
Market Cap (MRQ)
$719M
P/E
-4.4
EPS
$-1.87
ROE
-39.4%
52W Range
$7–$36
OLMA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.872019-12-31 → 2025-12-31
Free Cash Flow·2021-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | OLMA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -4.45Y avg ≈-5.7 | ≈-5.7 | · | · | |
| P/B (MRQ) | 1.75Y avg ≈2.0 | ≈2.0 | 3.5 | Undervalued | |
| Price / Cash Flow | -4.65Y avg ≈-7.2 | ≈-7.2 | · | · | |
| Price / Tangible Book | 1.45Y avg ≈2.0 | ≈2.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | OLMA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -33.0%5Y avg ≈-34.2% | ≈-34.2% | -33.0% | In line | |
| ROE | -39.4%5Y avg ≈-38.7% | ≈-38.7% | -39.4% | In line | |
| ROIC | -37.3% | · | -68.5% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | OLMA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 8.95Y avg ≈15.5 | ≈15.5 | 8.4 | In line | |
| Quick Ratio | 9.85Y avg ≈15.3 | ≈15.3 | 5.4 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.08%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $-0.61 | $-0.56 | -9.8% |
| March 31, 2026 | May 12, 2026 | $-0.52 | $-0.54 | 3.6% |
| Dec. 31, 2025 | $-0.50 | $-0.54 | 7.3% | |
| Sept. 30, 2025 | $-0.49 | $-0.49 | 0.67% | |
| June 30, 2025 | $-0.51 | $-0.38 | -33.0% | |
| March 31, 2025 | $-0.36 | $-0.52 | 30.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $158M | $125M | $86M | $82M | $51M | $14M | |
| SG&A Expense | $21M | $18M | $19M | $25M | $20M | $8M | |
| Operating Expenses | $179M | $142M | $105M | $107M | $71M | $22M | |
| Operating Income | $-179M | $-142M | $-105M | $-107M | $-71M | $-22M | |
| Interest Expense | · | · | · | · | · | $653.0K | |
| Interest Income | $16M | $13M | $8M | $2M | $442.0K | $60.0K | |
| Other Non-op | $23.0K | $102.0K | $-19.0K | $-27.0K | $-47.0K | · | |
| Pretax Income | $-162M | $-129M | · | · | · | · | |
| Income Tax | $3.0K | $2.0K | $2.0K | $1.0K | · | · | |
| Net Income | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| EPS (Basic) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| EPS (Diluted) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| Shares (Basic) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| Shares (Diluted) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| EBITDA | $-178M | $-142M | $-105M | $-107M | $-71M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $139M | $69M | $24M | $14M | $339M | |
| Short-term Investments | $457M | $295M | $193M | $181M | $273M | · | |
| Prepaid Expense | $10M | $4M | $5M | $4M | $3M | $4M | |
| Current Assets | $515M | $438M | $267M | $209M | $291M | $342M | |
| PP&E (Net) | $274.0K | $746.0K | $968.0K | $1M | $1M | $75.0K | |
| PP&E (Gross) | · | · | · | $2M | $2M | $137.0K | |
| Accum. Depreciation | · | · | · | $581.0K | $224.0K | $62.0K | |
| Other Non-current Assets | · | $15.0K | · | $3M | $540.0K | $510.0K | |
| Total Assets | $533M | $451M | $277M | $216M | $296M | $343M | |
| Accounts Payable | $9M | $4M | $3M | $374.0K | $23.0K | $719.0K | |
| Current Liabilities | $52M | $42M | $22M | $17M | $9M | $5M | |
| Capital Leases | $69.0K | $257.0K | $1M | $2M | $2M | · | |
| Total Liabilities | $55M | $42M | $23M | $18M | $11M | $5M | |
| Common Stock | $8.0K | $7.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.08B | $844M | $559M | $408M | $389M | $371M | |
| Retained Earnings | $-598M | $-435M | $-306M | $-209M | $-104M | $-33M | |
| AOCI | $621.0K | $143.0K | $347.0K | $-2M | $-149.0K | · | |
| Stockholders' Equity | $479M | $409M | $254M | $198M | $285M | $338M | |
| Liabilities + Equity | $533M | $451M | $277M | $216M | $296M | $343M | |
| Shares Outstanding | 81,376,449 | 74,312,608 | 54,992,784 | 40,287,097 | 39,797,263 | 39,308,238 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $490.0K | $393.0K | $377.0K | $357.0K | $163.0K | $11.0K | |
| Stock-based Comp | $18M | $23M | $17M | $19M | $16M | $3M | |
| Other Non-cash | $-2M | $2M | $-5M | $4M | $4M | · | |
| Operating Cash Flow | $-147M | $-104M | $-84M | $-82M | $-51M | $-20M | |
| CapEx | · | $159.0K | · | $363.0K | $2M | $56.0K | |
| Investing Cash Flow | $-156M | $-94M | $-5M | $91M | $-275M | $-56.0K | |
| Financing Cash Flow | $211M | $269M | $133M | $476.0K | $1M | $358M | |
| Net Change in Cash | $-91M | $71M | $45M | $10M | $-325M | $338M | |
| Free Cash Flow | · | $-105M | · | $-82M | $-52M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -33.0% | -35.6% | -39.2% | -41.0% | -22.3% | · | |
| ROE | -39.4% | -42.6% | -36.5% | -50.5% | -24.3% | · | |
| ROIC | -37.3% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 | · | |
| Quick Ratio | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | $5.50 | $4.62 | $4.90 | $7.15 | · | |
| Cash Flow / Share | $-1.69 | $-1.78 | $-1.85 | $-2.05 | $-1.28 | · | |
| Cash / Share | $0.59 | $1.88 | $1.25 | $0.59 | $0.35 | · | |
| EPS (TTM) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| Market Cap | $2.03B | $433M | $772M | $99M | $373M | · | |
| P/E | -13.4 | -2.6 | -6.6 | -0.9 | -5.2 | -14.1 | |
| P/B | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Tangible Book | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Cash Flow | -13.9 | -4.2 | -9.2 | -1.2 | -7.3 | · | |
| P / FCF | · | -4.1 | · | -1.2 | -7.1 | · | |
| Earnings Yield | -7.5% | -37.7% | -15.2% | -106.9% | -19.2% | -7.1% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $58M | $49M | $43M | $40M | $44M | $31M | $32M | $33M | $29M | $30M | $26M | $19M | $18M | $23M | $22M | $18M | |
| SG&A Expense | $9M | $9M | $7M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $7M | $6M | $6M | |
| Operating Expenses | $67M | $58M | $50M | $46M | $48M | $35M | $37M | $38M | $34M | $34M | $30M | $23M | $22M | $30M | $27M | $23M | |
| Operating Income | $-67M | $-58M | $-50M | $-46M | $-48M | $-35M | $-37M | $-38M | $-34M | $-34M | $-30M | $-23M | $-22M | $-30M | $-27M | $-23M | |
| Interest Income | $5M | $5M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $1M | $973.0K | $622.0K | |
| Other Non-op | $-528.0K | $121.0K | $13.0K | $12.0K | $38.0K | $-40.0K | $-93.0K | $138.0K | $40.0K | $17.0K | $93.0K | $-79.0K | $-44.0K | $11.0K | $67.0K | $-120.0K | |
| Net Income | $-63M | $-53M | $-46M | $-42M | $-44M | $-30M | $-34M | $-35M | $-30M | $-31M | $-27M | $-22M | $-20M | $-28M | $-26M | $-23M | |
| EPS (Basic) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| EPS (Diluted) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| Shares (Basic) | 104,453,732 | 102,800,098 | · | 85,732,221 | 85,497,426 | 85,426,223 | · | 57,262,803 | 56,282,402 | 55,574,324 | · | 44,977,161 | 40,720,294 | 40,354,493 | · | 40,036,201 | |
| Shares (Diluted) | 104,453,732 | 102,800,098 | · | 85,732,221 | 85,497,426 | 85,426,223 | · | 57,262,803 | 56,282,402 | 55,574,324 | · | 44,977,161 | 40,720,294 | 40,354,493 | · | 40,036,201 | |
| EBITDA | $-67M | $-58M | · | $-46M | $-48M | $-35M | · | $-38M | $-34M | $-34M | · | $-23M | $-22M | $-30M | · | $-23M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $53M | $48M | $35M | $52M | $51M | $139M | $36M | $17M | $34M | $69M | $117M | $35M | $41M | $24M | $27M | |
| Short-term Investments | $412M | $453M | $457M | $294M | $309M | $342M | $295M | $179M | $222M | $215M | $193M | $159M | $132M | $145M | $181M | $196M | |
| Prepaid Expense | $9M | $8M | $10M | $5M | $6M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $4M | $3M | $4M | $2M | |
| Current Assets | $470M | $513M | $515M | $334M | $368M | $397M | $438M | $218M | $242M | $252M | $267M | $282M | $172M | $189M | $209M | $225M | |
| PP&E (Net) | $382.0K | $356.0K | $274.0K | $486.0K | $560.0K | $653.0K | $746.0K | $849.0K | $945.0K | $1M | $968.0K | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $698.0K | $744.0K | $681.0K | · | $484.0K | |
| Other Non-current Assets | · | · | · | · | $15.0K | $14.0K | $15.0K | $15.0K | $16.0K | · | · | · | · | $3M | · | $3M | |
| Total Assets | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Accounts Payable | $2M | $4M | $9M | $3M | $934.0K | $151.0K | $4M | $3M | $4M | $8M | $3M | $2M | $2M | $681.0K | $374.0K | $14.0K | |
| Current Liabilities | $53M | $47M | $52M | $42M | $33M | $26M | $42M | $31M | $27M | $26M | $22M | $16M | $15M | $19M | $17M | $13M | |
| Capital Leases | $0 | $0 | $69.0K | $310.0K | $602.0K | $123.0K | $257.0K | $562.0K | $859.0K | $1M | $1M | $2M | $1M | $1M | $2M | $2M | |
| Total Liabilities | $56M | $50M | $55M | $45M | $37M | $26M | $42M | $31M | $27M | $27M | $23M | $18M | $16M | $21M | $18M | $14M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.15B | $1.13B | $1.08B | $858M | $854M | $849M | $844M | $600M | $594M | $573M | $559M | $554M | $419M | $413M | $408M | $403M | |
| Retained Earnings | $-714M | $-651M | $-598M | $-551M | $-509M | $-465M | $-435M | $-402M | $-367M | $-337M | $-306M | $-279M | $-257M | $-237M | $-209M | $-183M | |
| AOCI | $-947.0K | $-460.0K | $621.0K | $526.0K | $314.0K | $420.0K | $143.0K | $464.0K | $-118.0K | $-10.0K | $347.0K | $-241.0K | $-518.0K | $-978.0K | $-2M | $-3M | |
| Stockholders' Equity | $431M | $480M | $479M | $307M | $345M | $383M | $409M | $199M | $227M | $236M | $254M | $275M | $162M | $175M | $198M | $218M | |
| Liabilities + Equity | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Shares Outstanding | 87,452,166 | 87,332,971 | 81,376,449 | 68,652,730 | 68,627,886 | 68,333,065 | 74,312,608 | 57,288,319 | 57,246,411 | 55,867,863 | 54,992,784 | 54,601,516 | 41,122,482 | 40,438,320 | 40,287,097 | 40,084,568 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102.0K | $119.0K | $187.0K | $43.0K | $132.0K | $128.0K | $116.0K | $95.0K | $94.0K | $88.0K | $88.0K | $90.0K | $99.0K | $100.0K | $97.0K | $91.0K | |
| Stock-based Comp | $13M | $10M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $5M | $5M | $4M | |
| Other Non-cash | · | $-3M | · | · | · | $-18M | · | · | · | $2M | · | · | · | $3M | · | · | |
| Operating Cash Flow | $-46M | $-46M | $-38M | $-35M | $-30M | $-44M | $-26M | $-27M | $-28M | $-23M | $-18M | $-23M | $-22M | $-20M | $-20M | $-18M | |
| CapEx | · | · | · | $0 | · | · | $0 | $0 | $6.0K | $153.0K | · | · | · | · | $173.0K | $139.0K | |
| Investing Cash Flow | $41M | $5M | $-162M | $17M | $34M | $-45M | $-114M | $46M | $-5M | $-20M | $-31M | $-25M | $14M | $37M | $16M | $20M | |
| Financing Cash Flow | $1M | $46M | $214M | $41.0K | $-3M | $222.0K | $244M | $92.0K | $16M | $9M | $523.0K | $131M | $2M | $220.0K | $273.0K | $106.0K | |
| Net Change in Cash | $-4M | $4M | $13M | $-17M | $2M | $-89M | $104M | $19M | $-17M | $-35M | $-49M | $82M | $-6M | $17M | $-3M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-24M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.5% | -11.3% | · | -14.5% | -13.8% | -9.0% | · | -13.2% | -14.1% | -13.5% | · | -8.2% | -9.4% | -12.0% | · | -8.4% | |
| ROE | -16.3% | -12.3% | · | -16.7% | -15.3% | -9.8% | · | -14.6% | -15.6% | -15.1% | · | -8.7% | -10.1% | -12.9% | · | -8.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 10.9 | · | 8.0 | 11.1 | 15.2 | · | 7.1 | 9.1 | 9.6 | · | 17.7 | 11.6 | 9.8 | · | 17.9 | |
| Quick Ratio | 8.7 | 10.7 | · | 7.9 | 10.9 | 15.1 | · | 7.0 | 9.0 | 9.5 | · | 17.3 | 11.3 | 9.6 | · | 17.7 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.92 | $5.50 | · | $4.48 | $5.03 | $5.61 | · | $3.47 | $3.97 | $4.23 | · | $5.04 | $3.93 | $4.33 | · | $5.43 | |
| Cash Flow / Share | · | $-0.45 | · | · | · | $-0.51 | · | · | · | $-0.42 | · | · | · | $-0.51 | · | · | |
| Cash / Share | $0.56 | $0.60 | · | $0.51 | $0.76 | $0.74 | · | $0.63 | $0.30 | $0.60 | · | $2.15 | $0.85 | $1.01 | · | $0.67 | |
| EPS (TTM) | $-2.13 | $-2.03 | · | $-1.86 | $-1.97 | $-2.00 | · | $-2.17 | $-2.05 | $-2.00 | · | $-2.32 | $-2.41 | $-2.74 | · | $-2.51 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-205M | $-185M | · | $-150M | $-142M | $-129M | · | $-123M | $-110M | $-99M | · | $-96M | $-97M | $-110M | · | $-100M | |
| Market Cap | $1.09B | $1.30B | · | $672M | $292M | $257M | · | $684M | $619M | $632M | · | $674M | $371M | $140M | · | $111M | |
| P/E | -5.9 | -7.3 | · | -5.3 | -2.2 | -1.9 | · | -5.5 | -5.3 | -5.7 | · | -5.3 | -3.7 | -1.3 | · | -1.1 | |
| P/B | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Tangible Book | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Cash Flow | · | -28.3 | · | · | · | -5.8 | · | · | · | -26.9 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -17.0% | -13.6% | · | -19.0% | -46.2% | -53.2% | · | -18.2% | -18.9% | -17.7% | · | -18.8% | -26.7% | -79.0% | · | -90.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-162M | $-129M | $-97M | $-105M | $-71M |
| Diluted EPS | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 |
| Quick Ratio | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-105M | · | $-82M | $-52M |
Institutional owners (13F) 199 filers · $1.4B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
199
Value held
$1.4B
New positions
25
Exited positions
37
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 25 (-33 vs prior Q) | 37 (-10 vs prior Q) | 72 (-4 vs prior Q) | 68 (+15 vs prior Q) | -8.9M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $151,909,702 | 12,143,062 | 11.15% | Shares |
| Paradigm Biocapital Advisors LP | $108,468,906 | 8,670,576 | 7.96% | Shares |
| JANUS HENDERSON GROUP PLC | $106,013,431 | 7,108,488 | 7.78% | Shares |
| VANGUARD GROUP INC | $89,033,875 | 3,561,355 | 6.53% | Shares |
| Bain Capital Life Sciences Investors, LLC | $88,636,465 | 7,085,249 | 6.50% | Shares |
| BlackRock, Inc. | $84,000,783 | 6,714,691 | 6.16% | Shares |
| BVF INC/IL | $66,251,621 | 5,295,893 | 4.86% | Shares |
| Siren, L.L.C. | $60,760,432 | 4,856,949 | 4.46% | Shares |
| STATE STREET CORP | $53,993,886 | 4,316,058 | 3.96% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $41,798,625 | 3,341,217 | 3.07% | Shares |
| Logos Global Management LP | $40,143,026 | 3,208,875 | 2.95% | Shares |
| FRANKLIN RESOURCES INC | $29,393,321 | 2,349,586 | 2.16% | Shares |
| Cormorant Asset Management, LP | $26,896,500 | 2,150,000 | 1.97% | Shares |
| MORGAN STANLEY | $22,921,685 | 1,832,269 | 1.68% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $22,759,853 | 1,819,029 | 1.67% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20,806,857 | 1,663,218 | 1.53% | Shares |
| GOLDMAN SACHS GROUP INC | $19,615,417 | 1,567,979 | 1.44% | Shares |
| Deep Track Capital, LP | $18,765,000 | 1,500,000 | 1.38% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $17,718,405 | 1,416,533 | 1.30% | Shares |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | $16,954,790 | 1,355,299 | 1.24% | Shares |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $15,012,000 | 1,200,000 | 1.10% | Shares |
| TWO SIGMA INVESTMENTS, LP | $14,154,239 | 1,131,434 | 1.04% | Shares |
| Point72 Asset Management, L.P. | $13,397,572 | 1,070,949 | 0.98% | Shares |
| Defilade Capital Management, L.P. | $11,568,723 | 924,758 | 0.85% | Shares |
| AMERIPRISE FINANCIAL INC | $10,516,481 | 840,646 | 0.77% | Shares |
| Woodline Partners LP | $9,395,385 | 751,030 | 0.69% | Shares |
| Candriam S.C.A. | $9,387,633 | 751,133 | 0.69% | Shares |
| NORTHERN TRUST CORP | $8,443,561 | 674,945 | 0.62% | Shares |
| Vivo Capital, LLC | $8,404,756 | 671,843 | 0.62% | Shares |
| Qube Research & Technologies Ltd | $8,298,121 | 663,319 | 0.61% | Shares |
| CITADEL ADVISORS LLC | $8,029,268 | 641,828 | 0.59% | Shares |
| Squarepoint Ops LLC | $7,699,530 | 615,470 | 0.56% | Shares |
| READYSTATE ASSET MANAGEMENT LP | $7,428,801 | 593,829 | 0.55% | Shares |
| Jones Hill Capital LP | $7,182,817 | 574,166 | 0.53% | Shares |
| Hudson Bay Capital Management LP | $7,085,664 | 566,400 | 0.52% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $6,585,839 | 526,446 | 0.48% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6,484,458 | 518,342 | 0.48% | Shares |
| Vestal Point Capital, LP | $5,236,073 | 418,551 | 0.38% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $5,192,338 | 415,055 | 0.38% | Shares |
| Ikarian Capital, LLC | $4,794,845 | 383,281 | 0.35% | Shares |
| SEB Asset Management AB | $4,246,649 | 339,461 | 0.31% | Shares |
| BANK OF AMERICA CORP /DE/ | $4,189,287 | 334,875 | 0.31% | Shares |
| Fisher Asset Management, LLC | $3,712,015 | 296,724 | 0.27% | Shares |
| Rock Springs Capital Management LP | $2,942,077 | 235,178 | 0.22% | Shares |
| UBS Group AG | $2,788,141 | 222,873 | 0.20% | Shares |
| Bank of New York Mellon Corp | $2,779,441 | 222,177 | 0.20% | Shares |
| Pier Capital, LLC | $2,760,944 | 220,699 | 0.20% | Shares |
| Ikarian Capital, LLC | $2,502,000 | 200,000 | 0.18% | Call option |
| Birchview Capital, LP | $2,489,490 | 199,000 | 0.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,280,573 | 182,300 | 0.17% | Put option |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities GP LLC, Logos GP LLC ×4 filings | May 13, 2025 | 4.70% | Amendment | Passive investment | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×4 filings | Dec. 4, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 22 insiders · 10 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Sean Bohen | PRESIDENT AND CEO | Feb. 2, 2026 A | 237,650 | 0 | 0 | $0 |
| Jason O'Byrne | CHIEF FINANCIAL OFFICER | Sept. 1, 2026 A | · | 0 | 0 | $0 |
| Shawnte Mitchell | CHIEF LEGAL OFFICER | March 4, 2026 M | 0 | 0 | 3 | $-951,503 |
| Sasha Lu Austin | VP of Finance and Controller | Feb. 2, 2026 A | 16,188 | 0 | 0 | $0 |
| Naseem Zojwalla | CHIEF MEDICAL OFFICER | Feb. 2, 2026 A | 4,488 | 0 | 4 | $-7,530,148 |
| David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Feb. 2, 2026 A | 542,761 | 0 | 8 | $-4,660,773 |
| Shane William Charles Kovacs | CH. OPERATING & FINANCIAL OFF. | Jan. 15, 2026 S | 139,727 | 0 | 2 | $-2,980,054 |
| Kinney Horn | Chief Business Officer | Feb. 1, 2023 A | 2,458 | 0 | 0 | $0 |
| John B Moriarty | EVP, Ch. Legal Officer & Sec. | Feb. 1, 2023 A | · | 0 | 0 | $0 |
| Peter J. Kushner | CHIEF SCIENTIFIC OFFICER | Feb. 1, 2022 A | 1,431,672 | 0 | 0 | $0 |
| Cyrus Harmon | Director | July 24, 2026 S | 702,770 | 0 | 5 | $-743,720 |
| Prakash Raman | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Hrustanovic Gorjan | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Yi Larson | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Graham Walmsley | Director | June 18, 2026 A | 700,761 | 0 | 0 | $0 |
| Sandra Horning | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Scott J. Garland | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Ian T Clark | Director | June 18, 2026 A | 0 | 0 | 3 | $-7,873,109 |
| Cynthia M Butitta | Director | June 18, 2026 A | 83,876 | 0 | 0 | $0 |
| Andrew Rappaport | Director | June 18, 2026 A | 0 | 0 | 0 | $0 |
| Frank Mccormick | Director | Nov. 23, 2020 C | 84,260 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% owner | Nov. 23, 2020 C | 1,725,406 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 33 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.78% | 31,490 NS | July 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.21% | 92,322 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.20% | 265,667 SH | Sept. 11, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.11% | 180,516 SH | Aug. 19, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.06% | 1,261 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.06% | 541,502 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 56,779 SH | Aug. 19, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.05% | 6,145 SH | Oct. 2, 2026 | Daily |
| FFSM · FIDELITY COVINGTON TRUST | 0.03% | 41,085 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 451,269 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.03% | 37,461 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.03% | 2,009,029 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 69,692 SH | Oct. 2, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.02% | 233,776 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 652,061 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 14,261 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 157,394 SH | Aug. 19, 2026 | Daily |
| ISCG · iShares Trust | 0.01% | 8,630 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 124,208 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 24,851 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 186,331 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 1,955 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.00% | 2,323 SH | Sept. 11, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 8,460 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 21,603 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 79,879 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 17,563 SH | Sept. 10, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 16,063 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,611,290 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,103 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 608,966 SH | Sept. 11, 2026 | Daily |
| ISCB · iShares Trust | · | 2,951 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 8,558 SH | Sept. 11, 2026 | Daily |
OLMA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 18 analysts
BUY
Median target
$38.00
+362.0%
6 33.3%
Strong Buy
10 55.6%
Buy
2 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-28Mean target $36.50 +343.8%
← Below all targets
Current price $8.22
Low$16.00
Mean$36.50
High$59.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| OLMA | $2.03B | -13.4 | · | · | -39.4% | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| ACHV | · | -4.0 | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 10, 2026